265 related articles for article (PubMed ID: 33710684)
1. LncRNA HOTTIP inhibits cell pyroptosis by targeting miR-148a-3p/AKT2 axis in ovarian cancer.
Tan C; Liu W; Zheng ZH; Wan XG
Cell Biol Int; 2021 Jul; 45(7):1487-1497. PubMed ID: 33710684
[TBL] [Abstract][Full Text] [Related]
2. HOTTIP knockdown inhibits cell proliferation and migration via regulating miR-490-3p/HMGB1 axis and PI3K-AKT signaling pathway in ox-LDL-induced VSMCs.
Guo X; Liu Y; Zheng X; Han Y; Cheng J
Life Sci; 2020 May; 248():117445. PubMed ID: 32081664
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway.
Xiong L; Tang Y; Tang J; Liu Z; Wang X
Cancer Biother Radiopharm; 2020 Nov; 35(9):720-730. PubMed ID: 31910357
[No Abstract] [Full Text] [Related]
4. Long noncoding RNA HOTTIP promotes the metastatic potential of ovarian cancer through the regulation of the miR-615-3p/SMARCE1 pathway.
Wu H; Wei HY; Chen QQ
Kaohsiung J Med Sci; 2020 Dec; 36(12):973-982. PubMed ID: 32783402
[TBL] [Abstract][Full Text] [Related]
5. miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer.
Wang X; Liang Z; Xu X; Li J; Zhu Y; Meng S; Li S; Wang S; Xie B; Ji A; Liu B; Zheng X; Xie L
Cell Death Dis; 2016 Dec; 7(12):e2503. PubMed ID: 27906180
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of lncRNA HOTTIP Inhibits Retinoblastoma Progression by Modulating the miR-101-3p/STC1 Axis.
Yuan X; Sun Z; Cui C
Technol Cancer Res Treat; 2021; 20():1533033821997831. PubMed ID: 33784880
[TBL] [Abstract][Full Text] [Related]
7. LncRNA HOTTIP facilitates the stemness of breast cancer via regulation of miR-148a-3p/WNT1 pathway.
Han L; Yan Y; Zhao L; Liu Y; Lv X; Zhang L; Zhao Y; Zhao H; He M; Wei M
J Cell Mol Med; 2020 Jun; 24(11):6242-6252. PubMed ID: 32307830
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
Yang X; Xin N; Qu HJ; Wei L; Han Z
Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA OIP5-AS1 plays an oncogenic role in ovarian cancer through targeting miR-324-3p/NFIB axis.
Liu QY; Jiang XX; Tian HN; Guo HL; Guo H; Guo Y
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7266-7275. PubMed ID: 32706064
[TBL] [Abstract][Full Text] [Related]
10. LncRNA HOTTIP promotes proliferation and inhibits apoptosis of gastric carcinoma cells via adsorbing miR-615-3p.
Xiao ZS; Long H; Zhao L; Li HX; Zhang XN
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6692-6698. PubMed ID: 32633359
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-506-3p inhibits proliferation and promotes apoptosis in ovarian cancer cell via targeting SIRT1/AKT/FOXO3a signaling pathway.
Xia XY; Yu YJ; Ye F; Peng GY; Li YJ; Zhou XM
Neoplasma; 2020 Mar; 67(2):344-353. PubMed ID: 31973537
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA HOTTIP promotes hypoxia-induced glycolysis through targeting miR-615-3p/HMGB3 axis in non-small cell lung cancer cells.
Shi J; Wang H; Feng W; Huang S; An J; Qiu Y; Wu K
Eur J Pharmacol; 2019 Nov; 862():172615. PubMed ID: 31422060
[TBL] [Abstract][Full Text] [Related]
13. LncRNA CDKN2B-AS1 promotes the progression of ovarian cancer by miR-143-3p/SMAD3 axis and predicts a poor prognosis.
Xu C; Zhai J; Fu Y
Neoplasma; 2020 Jul; 67(4):782-793. PubMed ID: 32305052
[TBL] [Abstract][Full Text] [Related]
14. LncRNA SNHG20 promotes migration and invasion of ovarian cancer via modulating the microRNA-148a/ROCK1 axis.
Yang Q; Dong YJ
J Ovarian Res; 2021 Nov; 14(1):168. PubMed ID: 34836544
[TBL] [Abstract][Full Text] [Related]
15. LncRNA PVT1 promotes the progression of ovarian cancer by activating TGF-β pathway via miR-148a-3p/AGO1 axis.
Wu Y; Gu W; Han X; Jin Z
J Cell Mol Med; 2021 Sep; 25(17):8229-8243. PubMed ID: 34288373
[TBL] [Abstract][Full Text] [Related]
16. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
Shi J; Tan S; Song L; Song L; Wang Y
Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of long non-coding RNA XIST upregulates microRNA-149-3p to repress ovarian cancer cell progression.
Jiang R; Zhang H; Zhou J; Wang J; Xu Y; Zhang H; Gu Y; Fu F; Shen Y; Zhang G; Feng L; Zhang X; Chen Y; Shen F
Cell Death Dis; 2021 Feb; 12(2):145. PubMed ID: 33542185
[TBL] [Abstract][Full Text] [Related]
18. MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancer.
Xu H; Mao HL; Zhao XR; Li Y; Liu PS
J Ovarian Res; 2020 Mar; 13(1):31. PubMed ID: 32192508
[TBL] [Abstract][Full Text] [Related]
19. LncRNA HOTTIP promotes the proliferation and invasion of ovarian cancer cells by activating the MEK/ERK pathway.
Liu J; Hu HB; Liu YM; Li FX; Zhang LP; Liao ZM
Mol Med Rep; 2020 Nov; 22(5):3667-3676. PubMed ID: 33000231
[TBL] [Abstract][Full Text] [Related]
20. Long Noncoding RNA
Xie M; Zhang Z; Cui Y
Cancer Biother Radiopharm; 2020 Mar; 35(2):109-119. PubMed ID: 32077748
[No Abstract] [Full Text] [Related]
[Next] [New Search]